{
    "root": "30532bf0-5dc2-4d1b-e063-6394a90a119a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Phenobarbital",
    "value": "20250314",
    "ingredients": [
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "PHENOBARBITAL",
            "code": "YQE403BP4D"
        }
    ],
    "indications": "a. sedative b. anticonvulsant - treatment generalized partial seizures .",
    "contraindications": "dose phenobarbital must individualized full knowledge particular characteristics . factors consideration patient \u2019 age , weight , condition .",
    "warningsAndPrecautions": "16 fl oz ( 473 ml ) bottle ( ndc 62135-962-47 ) . 5 ml cups ( ndc 62135-962-05 ) 20 x 5 ml cups ( ndc 62135-962-24 ) . 7.5 ml cups ( ndc 62135-962-07 ) 20 x 7.5 ml cups ( ndc 62135-962-23 ) . 15 ml cups ( ndc 62135-962-15 ) 20 x 15 ml cups ( ndc 62135-962-22 ) . contains alcohol , 13.5 % dispense tight , light-resistant container defined usp/nf child resistant closure . shake well . keep tightly closed . store 20\u00b0 - 25\u00b0c ( 68\u00b0 - 77\u00b0f ) . [ usp controlled room temperature ] . manufactured : chartwell rx , llc . congers , ny 10920 l72434 rev . 02/2025",
    "adverseReactions": "phenobarbital contraindicated patients hypersensitive barbiturates , patients history manifest latent porphyria , patients marked impairment liver function respiratory disease dyspnea obstruction evident .",
    "indications_original": "A. Sedative \n    B. Anticonvulsant - For the treatment of generalized and partial seizures.",
    "contraindications_original": "The dose of phenobarbital must be individualized with full knowledge of its particular characteristics. Factors of consideration are the patient\u2019s age, weight, and condition.",
    "warningsAndPrecautions_original": "16 fl oz (473 mL) bottle (NDC 62135-962-47).\n                  5 mL cups (NDC 62135-962-05) and 20 x 5 mL cups (NDC 62135-962-24).\u00a0\n                  7.5 mL cups (NDC 62135-962-07) and 20 x 7.5 mL cups (NDC 62135-962-23).\u00a0\n                  15 mL cups (NDC 62135-962-15) and 20 x 15 mL cups (NDC 62135-962-22).\u00a0\n                  \n                  Contains alcohol, 13.5%\n                  Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.\n                  Shake well before use.\n                  Keep tightly closed. Store at 20\u00b0 - 25\u00b0C (68\u00b0 - 77\u00b0F). [see USP Controlled Room Temperature].\n                  \n                     \n                  \n                  \n                     Manufactured for: \n     Chartwell RX, LLC. \n     Congers, NY 10920\n  \n                  \n                  L72434\n                  Rev. 02/2025",
    "adverseReactions_original": "Phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident."
}